Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-03-03 @ 3:52 AM
Study NCT ID:
NCT04222920
Status:
COMPLETED
Last Update Posted:
2023-11-18
First Post:
2020-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adalimumab Dose Reduction Aiming Low Serum Concentration With Control of Disease Activity
Sponsor:
Reade Rheumatology Research Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Rheumatoid Arthritis | View |